JENNIFER CHIMENTO: Open Payments
NPI 1326280900 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 24 payments from 12 companies in 2025. Trend: 2023 $49 · 2024 $274 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $88 |
| Novo Nordisk Inc | 3 | $87 |
| SANOFI-AVENTIS U.S. LLC | 4 | $66 |
| Lilly USA, LLC | 3 | $50 |
| PFIZER INC. | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: REPATHA, TZIELD, Ozempic, MOUNJARO, VYNDAMAX, FARXIGA, NEXLETOL, Rybelsus.
Industry payments across GA — which companies pay providers there.
